http://www.fpnotebook.com/
Bullous Pemphigoid
- See Also
- Bullous Disease
- Pemphigoid
- Epidemiology
- Age of onset 60 to 80 years old
- Men and women affected equally
- Pathophysiology
- Autoimmune Subepidermal Blistering
- Symptoms
- Pruritus
- Lesions may be tender at borders
- Signs
- Initial Urticarial eruption
- Develops into large tense bullae after weeks to months
- Contain clear fluid or may at times be hemorrhagic
- Diffuse cutaneous involvement
- Often involves lower legs, forearms, thighs, groin
- Also involves abdomen
- Mucusa much less affected than in pemphigous vulgaris
- No scar formation
- Milia may form at previously involved sites
- Labs
- Histology
- Supepidermal Blister
- Superficial dermal inflammation
- Immunofluorescence
- IgG and C3 deposition along basement membrane zone
- Management
- First-Line
- Prednisone
- Methotrexate may be used for prednisone intolerance
- Topical Corticosteroids in localized mild cases
- Adjunctive agents (Corticosteroid sparing)
- Azathioprine
- Mycophenolate mofetil
- Tetracycline
- Course
- Self-limited condition
- Remits with treatment by 6 years in 50% of cases
- References
- Bickle (2002) Am Fam Physician 65:1861
- Cotell (2000) Am J Emerg Med 18(3):288
Bullous pemphigoid (C0030805)
|
|---|
| Definition (MSH) | A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis. |
| Concepts | Disease or Syndrome (T047)
|
| ICD9 | 694.5 |
| English | Bullous Pemphigoid, PEMPHIGOID, Pemphigoids |
| Spanish | penfigoide, penfigoide ampolloso |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
Navigation Tree